Browsing by Subject "B-cell malignancies"
Now showing items 1-1 of 1
New and emerging Bruton tyrosine kinase inhibitors for treating mantle cell lymphoma - where do they fit in? (Taylor & Francis, 2018-08)INTRODUCTION: Despite recent prognostic improvements, mantle cell lymphoma (MCL) remains incurable. Bruton tyrosine kinase (BTK) is a key receptor in B-cell tumorigenesis, and the benefits of the first BTK inhibitor, ...